14-03-2025 15:37 via medpagetoday.com

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) -- SAN FRANCISCO--A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Read more »

Medical news



Senior Investigator David Landsman, PhD, Selected as International Society for Computational Biology Fellow
Senior Investigator David Landsman, PhD, Selected as International Society for Computational Biology Fellow
Could Updating Urine Drug Screenings in Pregnancy Reduce Racial Inequities?
Statin Use Linked With Reduced Risks in Chronic Liver Disease
Adenotonsillectomy for Snoring in Kids Tied to Reduced Healthcare Use Later On
As AI Nurses Reshape Hospital Care, Human Nurses Are Pushing Back
I Didn't Match. What Do I Do Now?
A Promising Future for Metastasis-Directed Therapy in Prostate Cancer
NIH Removes Fauci Mural; Trump Deports Doctor; FDA Crackdown on Poppers?
Democratic Physician House Members Launch Congressional Doctors Caucus
Long-Acting ART Could Prevent More Infant HIV Infections in Zimbabwe
Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian Cancer
'People in Medicine Feel Very Threatened Right Now': What We Heard This Week
Add-On Metformin Promising in ER-Positive Endometrial Cancer
DIY Healthcare Can Help Counter the Physician Shortage
Desktop versie